Description:
Biogen Inc. is a leading biotechnology firm based in Cambridge, Massachusetts, renowned for its pioneering work in the discovery and development of innovative therapies for neurological disorders. The company boasts a comprehensive pipeline that addresses critical conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, positioning itself as a key player in meeting substantial unmet medical needs. Committed to advancing therapeutic innovation, Biogen leverages strategic partnerships and a deep commitment to scientific research, reinforcing its status as a prominent leader within the biotechnology industry and its dedication to improving patient outcomes.
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
225 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$24.8 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-47%
How much will you get:
$531
Prices dates:
30-10-2015: $290.51 and 31-10-2025: $154.27